Ownership history in Engineers Gate Manager LP · 14 quarters on record
This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in ACLARIS THERAPEUTICS INC (ACRS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 17,844 | +255 | +1.4% | 0.00% | $34K | $1.90 |
| 2025 Q2 | REDUCED | 17,589 | -22,653 | -56.3% | 0.00% | $25K | $1.42 |
| 2025 Q1 | REDUCED | 40,242 | -53,305 | -57.0% | 0.00% | $62K | $1.53 |
| 2024 Q4 | ADDED | 93,547 | +54,753 | +141.1% | 0.00% | $232K | $2.48 |
| 2024 Q3 | REDUCED | 38,794 | -21,742 | -35.9% | 0.00% | $45K | $1.15 |
| 2024 Q2 | ADDED | 60,536 | +3,398 | +5.9% | 0.00% | $67K | $1.10 |
| 2024 Q1 | REDUCED | 57,138 | -22,651 | -28.4% | 0.00% | $71K | $1.24 |
| 2023 Q4 | ADDED | 79,789 | +54,319 | +213.3% | 0.00% | $84K | $1.05 |
| 2023 Q3 | ADDED | 25,470 | +3,745 | +17.2% | 0.01% | $174K | $6.85 |
| 2023 Q1 | REDUCED | 21,725 | -5,728 | -20.9% | 0.01% | $176K | $8.09 |
As of 2025 Q4 — sorted by position size